ARCHIVES

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

This article is from The Cancer Letter archive.

Vol. 35 No. 39 | October 23, 2009

Download PDF Visit The Full Archive

Related Articles

DeVita Considers Alternatives to Recommendation Of NCAB On Organ Systems Coordinating Center

June 1, 1984

Intergroup 5-FU/Levamisole Study Positive Enough Now To End Untreated Control Arms

September 22, 1989

Cancer Advocates Seek 6.5% Increase For NCI In Fiscal 1997

March 8, 1996

News Analysis: The Political Economy of Importation to Alleviate Cancer Drug Shortages

March 2, 2012

Former NCI Lab Deputy Charged With Two Criminal Counts

January 17, 1992

NEJM Says Henschke Conflicts Irrelevant; Propriety Of Granting CME Questioned.

March 14, 2008